Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Almac Pharma Services has announced the appointment of two new Vice Presidents. Both will serve on the Almac Pharma Services’ Executive Leadership Team, reporting directly to John McQuaid, President & Managing Director of Almac Pharma Services.
read more
Almac Pharma Services announced the successful completion of its first FDA inspection of its commercial manufacturing facility in Charnwood, England.
read more
Almac Pharma Services announced the appointment of Terry Ernest as its new Director of Manufacturing Science and Technology.
read more
Tuesday, November 15, 2022
Almac Group announced that after the successful pre-approval inspection (PAI) of its Pharma Services’ operations located in Audubon, Pennsylvania by the FDA, the site has received product approval from the US FDA, UK Medicines and Healthcare products...
read more
Almac Pharma Services, a member of the Almac Group, has expanded its state-of-the-art Ultra-Low Temperature commercial packaging, labelling and distribution solutions to support the launch of Advanced Therapy Medicinal Products (ATMPs) from its ...
read more
Tuesday, January 28, 2014
Almac’s Diagnostics business unit today announced the publication of its breast cancer chemotherapy response assay in the Journal of the National Cancer Institute (JNCI).
read more
Thursday, August 01, 2013
In June 2013, Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, PA. ...
read more
Almac Group has welcomed confirmation from the EU’s medicines regulator, the EMA, that, post-Brexit, Northern Ireland will remain in regulatory alignment with the EU.
read more
Friday, February 22, 2013
Following from successful MHRA audits in 2011, Almac’s Sciences Business Unit has completed a successful inspection of its analytical facilities at its Craigavon Headquarters, Northern Ireland from the US Food and Drug Administration (FDA). The ...
read more
Almac’s diagnostics business unit today announced that it has received a Clinical Laboratory Permit from the New York State Department of Health, allowing them to receive patient samples for clinical testing from New York.
read more
Almac has been recognised for its cutting edge technological developments, scooping a top award at the recent Belfast Telegraph Northern Ireland Business Awards 2012, in association with British Midland International (bmi).
read more
Craigavon-based pharmaceutical development company Almac recorded pre-tax profits of £19.2m in 2013, up around 30% on the previous year, it has announced.
read more
Tuesday, September 16, 2014
Almac is named National Champion in the UKTI Award for Innovation category.
read more
Almac is pleased to announce the successful completion of the Knowledge Transfer Partnership (KTP) with Queens University, Belfast to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis ...
read more
As the Industry faces the tightest ever new heavy metal mandates from the FDA, stipulating the control and documentation, where appropriate, of all elemental impurities in drug products, drug substances and excipients, Almac has invested in state of ...
read more